Quantcast
Last updated on April 17, 2014 at 11:49 EDT

Latest Dopamine Stories

2012-11-27 13:58:22

New MRI technique could help doctors track how patients respond to treatment A new imaging technique developed at MIT offers the first glimpse of the degeneration of two brain structures affected by Parkinson's disease. The technique, which combines several types of magnetic resonance imaging (MRI), could allow doctors to better monitor patients' progression and track the effectiveness of potential new treatments, says Suzanne Corkin, MIT professor emerita of neuroscience and leader of...

2012-11-16 11:06:17

Transmission model shows two main hallmarks of Parkinson´s disease - death of dopamine neurons and disease protein clumps Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of Medicine, University of Pennsylvania have been able to piece together...

2012-11-13 13:33:12

Last year a clinical trial of L-DOPA -- a mainstay of Parkinson's disease therapy -- was launched for Angelman syndrome, a rare intellectual disorder that shares similar motor symptoms such as tremors and difficulty with balance. The clinical trial is based on a 10-year-old case report showing benefit with the drug, but few studies since have explored the neurological justification for using L-DOPA to treat parkinsonian features in Angelman syndrome. New research from the University of...

Studying The Influence Of ADHD Medications
2012-11-10 11:07:55

redOrbit Staff & Wire Reports — Your Universe Online Some drugs used to treat ADHD could affect the brain's reward system, researchers from the University of Copenhagen have discovered. The findings make it easier to understand how the medicine works and could ultimately lead to improvements in the development of and the dose determination associated with ADHD treatments, they report in the latest edition of the Journal of Neurophysiology. As part of the study, Jakob Kisbye...

Happy Hormone Curbs Memory Loss In Alzheimers
2012-11-09 12:09:26

Alan McStravick for redOrbit.com - Your Universe Online Alzheimer´s is an degenerative illness that slowly robs the sufferer of their long-term memory and, through the resultant dementia, often leaves them lost and unable to discern between present and past. There is a reason that Alzheimer´s disease is referred to as “the long goodbye”. Led by Emrah Düzel, researchers from of the University of Magdeburg in Germany are studying the effects of the...

Caffeine Increases Ability To Recognize Positive Words
2012-11-08 15:54:43

Brett Smith for redOrbit.com - Your Universe Online As any coffee drinker will tell you, the day immediately begins to feel better after taking that first earthy, faintly bitter sip o´ joe from the edge of a steaming cup. A new study from German researchers reinforces the positive aura swirling around the magical brown elixir as they have shown that caffeine can increase a person´s ability and speed in recognizing words with a positive connotation. The study also shows that...

2012-10-26 00:35:45

Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time. Their research could lead to a better understanding of many brain disorders, from drug addiction to depression, that share certain signaling molecules involved in modulating brain activity. A team led by Bernardo Sabatini, Takeda Professor of Neurobiology at Harvard Medical School, used mouse models to study dopamine neurons in the striatum, a region of...

2012-10-25 07:32:07

SUNNYVALE, Calif., Oct. 25, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has received positive behavioural efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data shows superiority of...

2012-10-01 02:29:48

SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing new treatments for brain-related disorders including Parkinson's disease and Traumatic Brain Injuries (TBI) centered on its proprietary anti-apoptotic therapeutic protein known as MANF, today announced the publication of a landmark research paper on MANF, Amarantus' lead development program. The studies were conducted at the University of Helsinki, a research...

2012-09-20 14:23:56

ROCHESTER, Minn., Sept. 20, 2012 /PRNewswire-USNewswire/ -- For far too many people, the symptoms are all-too familiar: uncomfortable, even painful, sensations in the legs while at rest. Tingling, twitching, throbbing or "antsy" feelings in the calves or thighs and even arms that make you want to get up, stretch, and move around. While these sensations can be hard to describe, the diagnosis isn't. It's called Restless Legs Syndrome (RLS/WED, or Willis-Ekbom disease) - and it affects...